Bill Helman is a partner with Greylock, a venture capital firm focused on early stage investments in technology, consumer internet, and health care. He joined Greylock in 1984 and has been a managing partner since 1997. Helman led Greylock’s investments in Aveo Pharmaceuticals, Millennium Pharmaceuticals, Hyperion Software, Vertex Pharmaceuticals, Filene’s Basement, UPromise, Reveal Imaging, and ZipCar, among others.
Helman is a Trustee at Dartmouth College and chairs the Investment Committee. In addition, he serves on the boards of Harvard Management Company, the Isabella Stewart Gardner Museum, and the Steppingstone Foundation. He is also a member of the Board of Fellows at Harvard Medical School and the Damon Runyon Cancer Research Foundation.
Helman graduated from Dartmouth in 1980 and from Harvard Business School in 1984.